Youssef’s syndrome has been first described in 1957 as an atypical presentation of a vesicouterine fistula after lower segment Cesarean section. It is characterized by a triad of cyclic hematuria, amenorrhea, and absence of urinary incontinence, which is usually found in other forms of genitourinary fistulas. We describe a case report of a woman who developed a delayed Youssef’s syndrome 3 months after her third Cesarean section. She was initially post-operatively treated conservatively and successfully for a bladder leakage through the wound with a bladder catheter for 1 month, and 2 months later, she developed symptoms as described above. She was successfully treated with uterus-sparing surgical fistula repair. Youssef’s syndrome is a rare and atypical presentation. Physicians may easily be misled and diagnosis delayed. We describe the diagnostic approach and review the literature as to therapeutic approaches.

1.
Youssef
AF
.
Menouria following lower segment cesarian section: a syndrome
.
Am J Obstet Gynecol
.
1957
;
73
:
759
64
.
2.
Optimizing Caesarean section use. [cited 2020 Mar 27]. Published October 12, 2018
. www.thelancet.com/series/caesarean-section.
3.
Tancer
ML
.
Vesicouterine fistula: a review
.
Obst Gynecol Surv
.
1986
;
41
(
12
):
743
53
.
4.
Knipe
WHW
.
Vesico-uterine fistula
.
Am J Obstet
.
1908
;
57
:
211
217
.
5.
Machado
L
.
Fistulas vesico-cervicais apos cesareana segmentar
.
Rev Gynec Obstet
.
1935
;
9
:
471
.
6.
Porcaro
AB
,
Zicari
M
,
Antoniolli
SZ
,
Pianon
R
,
Monaco
C
,
Migliorini
L
, et al.
Vesicouterine fistulas following cesarean section. Report on a case, review and update of the literature
.
Int Urol Nephrol
.
2002
;
34
:
335
44
.
7.
Machado
RA
 Jr
,
Machado
LC
 Jr
,
Lourenço
LL
.
Vesicouterine fistula (Youssef syndrome): case report and literature review
.
Rev Bras Ginecol Obstet
.
2018
;
40
(
9
):
563
9
.
8.
El Fassi
MJ
,
Tazi
K
,
Karmouni
T
,
Koutani
A
,
Ibn Attya
AA
,
Hachimi
M
, et al.
Youssef’s syndrome (vesico-uterine fistula): about three cases
.
Ann Urol
.
2003
;
37
:
184
6
.
9.
Rao
MP
,
Dwivedi
US
,
Datta
B
,
Vyas
N
,
Nandy
PR
,
Trivedi
S
, et al.
Post caesarean vesicouterine fistulae: Youssef syndrome: our experience and review of published work
.
ANZ J Surg
.
2006
;
76
(
4
):
243
5
.
10.
Yokoyama
M
,
Arisawa
C
,
Ando
M
.
Successful management of vesicouterine fistula by luteinizing hormone-releasing hormone analog
.
Int J Urol
.
2006
;
13
(
4
):
457
9
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.